Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments TA1023 11 December 2024 11 December 2024 ...

If you are interested in getting a health technology evaluated by NICE you should ensure that the product is registered with the NHS Innovation Service. That will ensure that it is considered in the ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Our guidance helps people in the NHS make efficient, cost-effective and consistent decisions about adopting new medical technologies. It supports innovation and transformation and improves healthcare ...

All NICE products on physical activity. Includes any guidance and quality standards.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

These resources provide access to high quality authoritative evidence and best practice. They are for anyone who works in health and social care and makes decisions about treatments, interventions, or ...